Biocomposites, an international medical devices company that engineers, manufactures, and markets products for use in infection management in bone and soft tissue, has announced that Argentina and Taiwan are the latest territories to approve STIMULAN as an antibiotic carrier that can be used in bone and soft tissue.
shutterstock
Approvals concept
They join a rapidly expanding list of territories which already includes UK, EU, Canada, Saudi Arabia, Mexico, and South Africa. In Canada and South Africa, STIMULAN is also approved to assist in wound healing and to treat bacterial infection in soft tissue surrounding bone.
STIMULAN Rapid Cure and STIMULAN Kit products are the first and only calcium matrices that can carry an antibiotic into bone and soft tissue, offering surgeons the flexibility to apply a broad spectrum of ‘off-the-shelf’ antibiotics. Already used globally in over 80,000 cases every year and in thousands of hospitals around the world, STIMULAN delivers the surgeon’s chosen antibiotics at concentration levels unachievable systemically – lowering rates of reinfection, decreasing hospital readmissions, and significantly improving patient outcomes.
Michael Harris, chief executive officer of Biocomposites, said: “STIMULAN is the leading calcium matrix for carrying antibiotics and the only one approved for use in bone and soft tissue. Adding Argentina and Taiwan to an already extensive list of countries, gives more surgeons the ability to tailor their infection treatment plans and transform patients’ lives.”
